#pdufa

Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA

FDA approves first drug for treatment of peanut allergy for children

FDA approves first drug for treatment of peanut allergy for children — Read on s2027422842.t.en25.com/e/es

This is a huge achievement for all food allergy companies.

Looking forward to this rise of this market.

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer — Read on s2027422842.t.en25.com/e/es

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update — Read on s2027422842.t.en25.com/e/es

Drug Trials Snapshots BRUKINSA | FDA

Drug Trials Snapshots — Read on www.fda.gov/drugs/resources-information-approved-drugs/drug-trials-snapshots-brukinsa

More inhibitors for oncology.

FDA approves new breakthrough therapy for cystic fibrosis | FDA

FDA approves breakthrough therapy Trikafta for patients 12 and older with cystic fibrosis who have at least one F508del mutation in the CFTR gene, estimated to represent 90% of the cystic fibrosis population. — Read on www.fda.gov/news-events/press-announcements/fda-approves-new-breakthrough-therapy-cystic-fibrosis

Ceritinib Response Seen in Study of Brain Metastases in ALK-Positive NSCLC

“The efficacy of ceritinib was evaluated in patients who have ALK-positive non-small cell lung cancer with active brain metastases.” — Read on www.pharmacytimes.com/conferences/esmo-congress-2019/https//www.pharmacytimes.com/

FDA approves new treatment for patients with migraine | FDA

The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow is not indicated for the preventive treatment of migraine. — Read on www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-patients-migraine